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Dexamethasone is usually prescribed concomitantly with other medications as anti-inflammatory 
and immunosuppressive agent and for management of respiratory distress syndrome. 
Concomitant usage of dexamethasone and other medications may alter electrolyte metabolism 
and increase the formation of potentially hepatotoxic reactive metabolites which can contribute 
to elevated liver enzymes. The role of dexamethasone in liver functions and electrolyte 
metabolism during pregnancy in Yankasa sheep and Sahel goat has not been determined. This 
study evaluated the effect of dexamethasone on the liver enzymes and to ascertain its role in 
electrolyte metabolism during pregnancy in Yankasa sheep and Sahel goat. Twenty four healthy 
adult animals comprising of 10 Sahel does and 2 bucks and 10 Yankasa ewes and 2 rams were 
used for this study. Pregnancies were achieved by natural mating after synchronization. Repeated 
dexamethasone injection was given at 0.25mg/kg body weight on days 1, 3 and 5 during first 
trimester; day 51, 53 and 55 during second trimester, and day 101, 103 and 105 during the third 
trimester. Blood samples were collected for sixteen weeks through the jugular vein.  Serum 
samples collected were used for the analysis of Alanine amino transferase (ALT), Aspartate 







) concentrations. Dexamethasone significantly (P<0.05) decreased AST, ALT, 
ALP and K
+




 concentrations remained unchanged. The 
decreased levels of liver enzymes suggest that dexamethasone possess some hepato-protective 
properties and no interspecies difference in the liver response and mineral metabolism following 
dexamethasone treatment during gestation. 
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INTRODUCTION 
Small ruminants are widely distributed in 
the tropics and are considered as major 
livestock species in Africa (Peacock, 1996). 
They are increasingly becoming a primary 
source of dietary animal protein in Nigeria 
and contribute greatly to the Nigerian socio 
economic development (Gall, 1996). 
However, the profitability of sheep and 
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goats depends largely on their management 
and health (Lakpini, 2002). The herders will 
therefore usually do all within their powers 
using available resources to provide best 
management practice and health care 
services to ensure continuity of the business. 
The result of this is increased demand for 
health care and veterinary services. 
Dexamethasone is a commonly used drug in 
veterinary practice (Aliu, 2007).  
Dexamethasone is a derivative of 
corticosteroids and has similar 21 carbon 
steroid skeleton as hydrocortisone (Pierre-
louis, 2010; Aliu, 2007). Administration of 
dexamethasone is a common clinical 
practice especially in pregnant subjects 
(Hankinson et al., 1999; Aliu, 2007; Pierre-
Louis, 2010). In addition to its anti-
inflammatory and analgesic use, 
dexamethasone is also employed in the 
treatment of pregnancy related metabolic 
diseases such as ketosis, pregnancy toxemia 
and mastitis (McDonald, 1990; Aliu, 2007), 
prenatal foetal lung development and 
maturation as well as management of 
neonatal diseases (Liggins and Howie, 1972; 
Christer, 1994). Unfortunately, the 
dexamethasone use has been associated with 
intra uterine growth foetal restriction 
(IUGR), decrease birth weight and placental 
weights in some animal models as well as 
humans (Mathews, 2000; Bloom et al., 
2001; Kranendonk et al., 2006; Baisden et 
al., 2007; Yahi et al., 2017). Some authors 
have extrapolated that the adverse effects of 
dexamethasone can be counterbalanced by 
its benefits and that the benefits seem to 
outweigh the adverse effects or risk (Park et 
al., 2002). Hence despite its adverse effects, 
dexamethasone is now on the World health 
Organization (WHO) list of essential 
medicine, as among the most important 
medications needed in a basic health care 
system (WHO, 2015). However, different 
species do not always respond to medicines 
in the same way due to differences in 
anatomy, metabolism and inherent 
pharmacokinetics. 
One of the most important changes during 
pregnancy is the increase in metabolism, 
including minerals and electrolytes 
metabolism. For example greater amounts of 
calcium, potassium and sodium are needed 
for the developing bones, erythropoiesis and 
to provide nourishment to the growing 
foetus as well. Liver enzymes such as AST 
and ALT are widely distributed enzymes, 
which are found in many tissues and organs, 
with a particularly high activity in the liver 
(Zimmerman et al., 1986). Evaluation of 
liver enzymes activities is of diagnostic 
importance in pregnant subjects (Seifi et al., 
2007) and reports have shown an 
interspecies difference with respect to 
maternal leukocytic response (Yahi et al., 
2016) and foetal response (Yahi et al., 2017) 
to dexamethasone treatment. The objective 
of this study was to investigate and compare 
effects of dexamethasone on serum liver 
enzymes and electrolytes in pregnant 
Yankasa sheep and Sahel goat. 
 
MATERIALS AND METHODS 
We adopted some aspects of the methods of 
Yahi et al. (2016) and Yahi et al. (2017) in 
our methodology. 
A total of 24 adult healthy animals 
comprising of 10 Sahel does and 2 bucks 
and 10 Yankasa ewes and 2 rams were used 
for this study. Their known mean gestational 
lengths were 148.35 ± 1.50 days for 
Yankasa sheep and 148.33 ± 1.58 days for 
Sahel goats respectively (Rwuaan et al., 
1993; Waziri et al., 2010). The animals were 
purchased from main livestock market and 
private farms in Maiduguri metropolis. The 
ages of the does ranged between 2 and 3 
years and the bucks ranged from 2½ to 3 
years, while that of the ewes and the rams 
were 3 to 3½ years old, based on dentition 
and breeding history (Dyce et al., 1987). 
The does weighed between 22 to 25 kg and 
the bucks 29 kg and 32 kg. The ewes 
weighed between 33 to 37 kg; the weights of 
the rams were 40 to 45 kg. The body 
condition score (BCS) between 3.0 and 3.5 
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was maintained during the period of the 
experiment in all the animals. They were 
managed intensively in the University of 
Maiduguri Livestock research Farm and 
were acclimatized for six weeks before the 
commencement of the experiment. The feed 
rations consisted of wheat offal, beans husks 
and hay from groundnut leaves. Mineral salt 
licks and water were provided ad libitum. 
During the stabilization period, the animals 
were treated with oxytetracycline LA 
(Introxin-200®, Interchiemie, Venray, 
Holland) at 20 mg/kg body weight I/M and 
ivermectin (paramectin®, Pharma Swede, 
Egypt) at 200 μg/kg body weight. The males 
and the females were initially kept in 
different pens until the time of service.  
 
Estrus Synchronization 
At the end of the acclimatization period, the 
animals were synchronized using 
cloprostenol (Estrumate®, Schering Trough 
Animal, Germany) at 250 μg given 
intramuscularly 11 - day interval, as 
described previously (Akusu and Egbunike, 
1984). The females were teased with 
apronned males daily and all the females 
that came into estrus after the second 
treatment were allowed to be served 
naturally by the male. Days of estrus were 
recorded and considered as day 0 of the 
gestation. After successful synchronization 
and fertile mating, they were randomly 
separated into 4 groups of 5 each. The 
groups were as follows: Dexamethasone 
treated Sheep (DTS), Non dexamethasone 
treated Sheep (NDS), Dexamethasone 
treated goat (DTG) and Non dexamethasone 
treated goat (NDG). The non-treated groups 
served as control. 
 
Dexamethasone Treatment  
The animals in the dexamethasone treated 
group were administered dexamethasone 
(Dexaphan®, Pharma Pharmaceuticals, 
Swede-Egypt) intramuscularly at 0.25 
mg/kg body weight on days 1, 3 and 5 
during first trimester; days 51, 53 and 55 
during second trimester, and days 101, 103 
and 105 during the third trimester. The 
animals were observed for possible clinical 
changes throughout the period of the study. 
Their initial body weights, rectal 
temperatures, pulse rates and respiratory 
rates were recorded. This was continued at 
two weeks interval during the study (data 
not presented in this study). Pregnancies 
were later confirmed by failure to return to 
estrus and by ultrasonograhic examination.  
 
Blood Sample Collection and Analysis  
Five milliliters of blood samples were 
collected from day 0 from each animal in all 
groups and thereafter on biweekly basis for 
sixteen weeks through the jugular vein on 
the same day with minimal excitement prior 
to feeding. The blood samples of each 
animal were placed in sterile sample bottles 
without anticoagulant and the blood was 
allowed to clot. The serum was harvested 
and stored at -20
o
C for the analysis of liver 
enzymes and serum electrolytes. Alanine 
amino transferase (ALT) and Aspartate 
amino-transferase (AST) levels were 
determined using methods described by 
Reitman and Frankel (1957) as modified by 
Wright et al. (1972), using Randox 
Laboratories kits. Alkaline Phosphatase 
(ALP) was determined using methods 
described by Babson et al. (1966). The 
serum concentrations of calcium (Ca
2+
) were 
determined by method described by Lorentz 
(1982). Sodium (Na
+
) and potassium (K
+
) 
concentrations were determined by flame 
photometry according to the method 
described by Treitz (1994). 
 
RESULTS 
The changes in the values of liver enzymes 







 following prenatal 
dexamethasone treatments are presented in 
Tables 1 and 2. The results showed that 
AST, ALT and ALP levels were 
significantly (p < 0.05) lower in 
dexamethasone-treated pregnant dams in 
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                                                                                            Sheep  (N = 10)              
   Periods of observation (days)   
  0 14 28 42 56 70 84 98 112 













 NDS 60.50+0.52 60.50+0.26 58.29+0.29 54.47+0.55 53.56+0.45 53.40+0.38 52.70+0.44 50.40+0.38 50.52+0.44 









 NDS 35.27+0.56 35.29+0.25 33.30+0.29 34.20+0.24 32.75+0.21 32.52+0.33 32.47+0.48 33.61+0.18 33.20+0.20 


















                                                                                             Goat  (N = 10) 
   Periods of observation (days)   
  0 14 28 42 56 70 84 98 112 











 NDS 58.42+0.35 58.45+0.33 58.45+0.23 58.41+0.32 57.65+0.22 57.50+0.48 58.37+0.35 58.40+0.20 57.34+0.31 
           









 NDS 33.62+0.36 33.89+0.57 33.60+0.28 34.31+0.29 34.35+0.35 33.71+0.20 33.58+0.49 34.40+0.19 34.38+0.21 
           









 NDS 45.26+0.31 45.34+0.29 48.28+0.42 49.50+0.23 49.37+0.38 51.92+0.41 58.19+0.24 58.86+0.35 59.31+0.28 
DTS = Dexamethasone treated sheep; NDS = Non dexamethasone treated sheep (Control); DTG = Dexamethasone treated goat; NDG = Non 
dexamethasone treated goat (Control); AST=Aspartate amino transferase; ALT=Alkaline amino transferase; ALP=Alkaline phosphatase 
b 
=Significant (p<0.05) decrease compared to respective control group 
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                                                                                           Sheep  (N = 10)                
   Periods of observation (days)   
  0 14 28 42 56 70 84 98 112 
Ca
2+
(mmol/L) DTS 8.33+0.6 8.35+0.31 8.34+0.42 8.33+0.35 8.35+0.35 8.34+0.29 8.36+0.20 8.34+0.31 8.36+0.23 
 NDS 8.34+0.5 8.34+0.30 8.35+0.35 8.33+0.36 8.34+0.32 8.33+0.21 8.35+0.19 8.34+0.30 8.35+0.33 
           
K
+









 NDS 4.25+0.28 4.26+0.20 4.26+0.25 4.26+0.23 4.24+0.29 4.25+0.28 4.25+0.30 4.24+0.30 4.27+0.21 
           
Na
+
(mmol/L) DTS 137.20+1.01 138.10+1.11 138.1+1.07 137.30+1.02 137.30+1.06 138.20+1.05 138.12+1.10 137.01+1.01 137.40+1.10 





                                                                                              Goat (N = 10) 
   Periods of observation (days)   
  0 14 28 42 56 70 84 98 112 
Ca
2+
(mmol/L) DTG 8.20+0.40 8.23+0.20 8.22+0.20 8.23+0.18 8.21+0.22 8.22+0.27 8.20+0.22 8.23+0.19 8.21+0.24 
 NDG 8.22+0.20 8.24+0.18 8.20+0.32 8.23+0.17 8.22+0.15 8.22+0.26 8.21+0.20 8.23+0.19 8.23+0.24 
           
K
+











 NDG 4.51+0.17 4.51+0.31 4.54+0.24 4.54+0.35 4.52+0.31 4.53+0.19 4.52+0.26 4.52+0.21 4.55+0.0.38 
           
Na
+
(mmol/L) DTG 141.0+1.10 142.0+1.10 142.2+1.06 141.11+1.10 142+1.12 141.30+1.04 142.1+1.0 141.20+1.10 141.20+1.12 
 NDG 141.12+1.0 142.20+1.10 142.0+1.04 141+12+1.10 142.0+1.11 142.40+1.13 142.0+1.0 142.10+1.20 141.30+1.05 
DTS = Dexamethasone treated sheep; NDS = Non dexamethasone treated sheep (Control); DTG = Dexamethasone treated goat; NDG = Non dexamethasone 
treated goat (Control); 
 
b 
=Significant (p<0.05) decrease compared to respective control group 
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both species compared to their respective 
control groups. The effects were mainly 
observed from mid-gestation and extended 
to day 112 of gestation. The Ca
2+ 
concentrations remained unchanged in both 
groups while the K
+
 levels were 
significantly lower from day 70 of gestation 
in dexamethasone-treated pregnant Yankasa 
sheep compared to control. Similar trend 
was observed in goats, except that 
Potassium (K
+
) decrease occurred earlier 






remained unchanged in both groups.
 
DISCUSSION 
Glucocorticoid helps to maintain cell 
membrane integrity and prevents AST 
leakage into the general circulation (Adams, 
2001). This fact may explain the observed 
lower AST and ALT concentrations in 
dexamethasone treated groups compared to 
the control in both sheep and goats. ALT 
and AST evaluation is part of analyzing 
biochemical parameters analyzed in 
pregnant subjects (Seifi et al., 2007). The 
significant decrease in ALT and AST 
observed in this study suggests reduction in 
liver damage or breakdown (Jorritsma et al., 
2004), which implies liver friendly and 
beneficial effect. Therefore dexamethasone 
may be used as prophylactic treatment 
before administering drugs with hepatotoxic 
potential like pain relief medications, anti-
seizure medications and some classes of 
antibiotics such as sulfonamides and 
nitrofurantoin during gestation. The 
decrease in liver enzymes observed in this 
study is similar to findings in previous study 
by Halil et al. (2006) who reported decrease 
in liver enzymes and reduction in liver 
damage due to bile duct ligation in rats 
The decrease in ALP in dexamethasone 
treated groups in both species on the other 
hand, may be due to placental malfunctions 
as established in previous studies 
(McDonald et al., 2003; Ain et al., 2005; 
Hewitt et al., 2006; Sanhu, 2013; Yahi et al., 
2017).  Based on the data obtained in the 
present study, the liver function markers 
were not elevated, rather decreased, which 
implies liver friendly and beneficial effect of 
dexamethasone and that livers were not 
damage by the dexamethasone treatments. 
Therefore, the decrease in the ALP 
concentration in the dexamethasone treated 
groups in both species may be due to 
placental malfunctions.  This is because 
ALP is a product mainly from liver and 
placenta (Nduka, 1997; Tietz, 1999). 
The mechanism underlying the decrease in 
K
+ 
is not clear; however, the decrease could 
be due to increased urinary K
+ 
excretion 
without corresponding effects on sodium or 
calcium excretion. A similar observation 
was made by Johnson et al. (2009) in rats 
where dexamethasone injection produced 
70% increase in urinary K
+ 
excretion. The 





species on the other hand could be due to 
lack of mineralocorticoid activity of 
dexamethasone (Trine et al., 2008; Pierre-
Louis, 2010). Dexamethasone is known to 
have virtually no mineralocorticoid effect, 
but remains a potent anti-inflammatory and 
analgesic glucocorticoid with broad 
significant physiological and therapeutic 
uses (Trine et al., 2008; Pierre-Louis, 2010). 
 
CONCLUSION  
This study has further confirmed that 
dexamethasone decreases liver enzymes and 
potassium levels during pregnancy in sheep 
and goat but has no effects on calcium and 
sodium metabolism. The reduction in liver 
damage markers is probably one of the 
beneficial effects of dexamethasone. Unlike 
previous reports which shown an 
interspecies difference with respect to 
maternal leukocytic and foetal responses to 
dexamethasone treatment, there is no 
difference in the liver response and mineral 
metabolism between pregnant sheep and 
goat following dexamethasone treatment.  
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